The University of Calgary will recruit a new genitourinary cancer researcher, thanks to a $2M donation from the Prostate Cancer Centre and Remington Development. The new position—based at the Arnie Charbonneau Cancer Institute in the Cumming School of Medicine—will focus on advancing diagnostics and treatment for prostate, bladder, kidney, and other genitourinary cancers. “It is so important to recognize that generous gifts like this help bring the best to Calgary and [accelerate] research to unlock new understandings and more effective diagnostics and treatments,” said UCalgary Arnie Charbonneau Cancer Institute Director Jennifer Chan. The new researcher is expected to begin in 2026.
UCalgary
